Dark
Light
System
Institutional Investment Manager
SABBY MANAGEMENT, LLC
SABBY MANAGEMENT, LLC (CIK: 0001535610) incorporated in Delaware, located at 1011 Links Dr, Miami Beach, FL. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q3)
Portfolio Summary: 379 holdings with a total value of $2,427,276,000.
#
Name
Shares
Value ($)
%
Options
Notes
51 ALEXION PHARMACEUTIC 49,397 7,725,000 0.32%
52 EXACT SCIENCES CORP 4,293 7,723,000 0.32% Put
53 PERRIGO CO PLC 491 7,722,000 0.32% Call
54 KITE PHARMA INCORPORATED 137,099 7,634,000 0.31%
55 BLUEBIRD BIO INC 889 7,605,000 0.31% Call
56 ACADIA PHARMACEUTICALS INC 2,259 7,471,000 0.31% Put
57 MEDICINES CO 5,000,000 7,278,000 0.30%
58 MYLAN N V 1,747 7,033,000 0.29% Call
59 TOKAI PHARMACEUTICALS INC COM 654,283 6,772,000 0.28%
60 MANNKIND CORP 20,875 6,701,000 0.28% Put
61 BLUEPRINT MEDICINES CORP COM 308,504 6,583,000 0.27%
62 GW PHARMACEUTICALS PLC 71,757 6,556,000 0.27%
63 BIOMARIN PHARMACEUTICAL INC 0.75 10/15/2018 5,000,000 6,459,000 0.27%
64 ALNYLAM PHARMACEUTICALS INC 789 6,340,000 0.26% Put
65 ANADARKO PETE CORP 1,023 6,178,000 0.25% Put
66 ANADARKO PETE CORP 102,300 6,178,000 0.25%
67 NOVAVAX INC 8,418 5,952,000 0.25% Put
68 SAREPTA THERAPEUTICS INC 1,836 5,895,000 0.24% Put
69 BARCLAYS BK PLC IPATH S&P MT ETN 450,500 5,861,000 0.24%
70 SPARK THERAPEUTICS INC 1,402 5,851,000 0.24% Call
71 SPARK THERAPEUTICS INC 1,379 5,755,000 0.24% Put
72 THERAPEUTICSMD INC 9,800 5,743,000 0.24% Call
73 NEUROCRINE BIOSCIENCES INC 1,403 5,583,000 0.23% Call
74 KONINKLIJKE PHILIPS N V 2,374 5,569,000 0.23% Call
75 INTRA-CELLULAR THERAPIES INC 1,378 5,518,000 0.23% Call
76 OPKO HEALTH INC 6,456 5,429,000 0.22% Put
77 HALOZYME THERAPEUTICS INC 4,014 5,391,000 0.22% Call
78 EXACT SCIENCES CORP 289,112 5,201,000 0.21%
79 OPKO HEALTH INC 615,157 5,173,000 0.21%
80 FLUIDIGM CORP DEL COM 628,260 5,095,000 0.21%
81 DYNAVAX TECHNOLOGIES CORP 2,073 5,087,000 0.21% Call
82 DEPOMED INC 2,680 5,052,000 0.21% Call
83 GENOCEA BIOSCIENCES INC 729,141 4,995,000 0.21%
84 Nivalis Therapeutics Inc 384,734 4,990,000 0.21%
85 HCA HOLDINGS INC 624 4,827,000 0.20% Call
86 ACHILLION PHARMACEUTICALS INC 6,916 4,779,000 0.20% Call
87 ACADIA PHARMACEUTICALS INC 1,438 4,755,000 0.20% Call
88 AVALANCHE BIOTECHNOLOGIES IN 574,260 4,732,000 0.19%
89 CELLDEX THERAPEUTICS INC NEW 4,448 4,688,000 0.19% Call
90 ISIS PHARMACEUTICALS INC 1,159 4,685,000 0.19% Call
91 DERMIRA INC COM 190,000 4,435,000 0.18%
92 GILEAD SCIENCES INC 45,140 4,432,000 0.18%
93 ARBUTUS BIOPHARMA CORP 725,007 4,415,000 0.18%
94 RAPTOR PHARMACEUTICAL CORP 7,289 4,410,000 0.18% Call
95 NEUROCRINE BIOSCIENCES INC 1,267 4,397,000 0.18% Put
96 INOVIO PHARMACEUTICALS INC 737,551 4,263,000 0.18%
97 ZS PHARMA INC 640 4,202,000 0.17% Put
98 ENDO INTL PLC 601 4,164,000 0.17% Call
99 RADIUS HEALTH INC 578 4,006,000 0.17% Call
100 HERON THERAPEUTICS INC COM 160,323 3,912,000 0.16%
Page 2 of 8

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-065626, filed 2015.11.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.